Accessibility navigation


Bayesian decision procedures for dose-escalation based on evidence of undesirable events and therapeutic benefit.

Whitehead, J., Zhou, Y., Stevens, J., Blakey, G., Price, J. and Leadbetter, J. (2006) Bayesian decision procedures for dose-escalation based on evidence of undesirable events and therapeutic benefit. Statistics in Medicine, 25 (1). pp. 37-53. ISSN 0277-6715

Full text not archived in this repository.

To link to this article DOI: 10.1002/sim.2201

Abstract/Summary

In this paper, Bayesian decision procedures are developed for dose-escalation studies based on bivariate observations of undesirable events and signs of therapeutic benefit. The methods generalize earlier approaches taking into account only the undesirable outcomes. Logistic regression models are used to model the two responses, which are both assumed to take a binary form. A prior distribution for the unknown model parameters is suggested and an optional safety constraint can be included. Gain functions to be maximized are formulated in terms of accurate estimation of the limits of a therapeutic window or optimal treatment of the next cohort of subjects, although the approach could be applied to achieve any of a wide variety of objectives. The designs introduced are illustrated through simulation and retrospective implementation to a completed dose-escalation study. Copyright © 2006 John Wiley & Sons, Ltd.

Item Type:Article
Refereed:Yes
Divisions:Faculty of Science > School of Mathematical and Physical Sciences > Department of Mathematics and Statistics > Applied Statistics
ID Code:9434
Uncontrolled Keywords:Bayesian decision procedure , continual reassessment method , dose-escalation , logistic regression , phase I clinical trial

Centaur Editors: Update this record

Page navigation